angiotensin ii has been researched along with Shock, Cardiogenic in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (80.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (6.67) | 24.3611 |
2020's | 2 (13.33) | 2.80 |
Authors | Studies |
---|---|
Berry, TP; Haines, MM; Kozinn, J; Mohamed, A; Thomas, EL; Welge, JA; Zhurav, L | 1 |
Bansal, M; Belford, PM; Khanna, AK; Mehta, A; Vallabhajosyula, S; Wieruszewski, PM; Zhao, DX | 1 |
Boldt, DW; Gunnerson, K; Harper, MD; Lim, GW; Ostermann, M | 1 |
Miyazaki, M | 1 |
Ledingham, IM; Routh, GS | 1 |
Lapshina, LA; Vlasenko, MA | 1 |
Miyazaki, M; Yukioka, N | 1 |
Bailey, RW; Bulkley, GB; Oshima, A | 1 |
Kones, RJ | 1 |
Heublein, B; Parsi, RA | 1 |
Chazov, EI | 1 |
McCann, WD; O'Donovan, TP | 1 |
Austen, WG; Buckley, MJ; Gold, HK; Leinbach, RC; Mundth, ED; Sanders, CA | 1 |
Ahlquist, RP | 1 |
Moran, NC | 1 |
3 review(s) available for angiotensin ii and Shock, Cardiogenic
Article | Year |
---|---|
Efficacy and safety of angiotensin II in cardiogenic shock: A systematic review.
Topics: Angiotensin II; Arterial Pressure; Humans; Norepinephrine; Peptide Hormones; Shock; Shock, Cardiogenic; Vasoconstrictor Agents | 2023 |
[Clinical indices for reversible and irreversible shock and their thresholds].
Topics: Angiotensin II; Animals; Cardiac Output; Humans; Lung; Mononuclear Phagocyte System; Pancreas; Renin; Shock; Shock, Cardiogenic | 1980 |
Cardiogenic shock: therapeutic implications of altered myocardial energy balance.
Topics: Adrenergic alpha-Antagonists; Aerobiosis; Anaerobiosis; Angiotensin II; Assisted Circulation; Blood Pressure; Cardiac Output; Coronary Circulation; Digitalis Glycosides; Dopamine; Electric Countershock; Epinephrine; Glucagon; Glucocorticoids; Heart; Heart Function Tests; Heart Rate; Heart Ventricles; Humans; Isoproterenol; Metaraminol; Muscle Contraction; Myocardium; Norepinephrine; Oxygen Consumption; Pacemaker, Artificial; Propranolol; Shock, Cardiogenic | 1974 |
12 other study(ies) available for angiotensin ii and Shock, Cardiogenic
Article | Year |
---|---|
Angiotensin II in Patients With Shock on Mechanical Circulatory Support: A Single-Center Retrospective Case Series.
Topics: Angiotensin II; Extracorporeal Membrane Oxygenation; Female; Heart-Assist Devices; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Shock; Shock, Cardiogenic | 2022 |
Angiotensin in ECMO patients with refractory shock.
Topics: Adult; Angiotensin II; Angiotensins; Extracorporeal Membrane Oxygenation; Female; Humans; Male; Middle Aged; Shock; Shock, Cardiogenic; Shock, Septic; Vasoconstrictor Agents | 2018 |
The pathophysiology of shock.
Topics: Angiotensin II; Blood Circulation; Blood Viscosity; Body Fluids; Catecholamines; Heart; Hematocrit; Histamine; Humans; Hydrogen-Ion Concentration; Kidney; Kinins; Liver; Lung; Oxygen Consumption; Oxyhemoglobins; Prostaglandins; Respiration; Shock; Shock, Cardiogenic; Vasoconstriction; Vasodilation | 1979 |
[Humoral mechanisms of renin-angiotensin system activation in macrofocal myocardial infarct].
Topics: Adult; Aged; Angiotensin II; Angiotensinogen; Endopeptidases; Enzyme Activation; Epinephrine; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Renin; Shock, Cardiogenic | 1979 |
Renal blood flow in various types of hypotension and shock in dogs and men (preliminary report).
Topics: Angiotensin II; Animals; Catecholamines; Dogs; Hemodynamics; Humans; Hypotension, Controlled; Kidney; Regional Blood Flow; Renin; Shock; Shock, Cardiogenic; Shock, Hemorrhagic; Shock, Septic | 1978 |
Pathophysiology of hepatic ischemia in cardiogenic shock.
Topics: Angiotensin II; Animals; Cardiac Output; Central Venous Pressure; Disease Models, Animal; Hemodynamics; Ischemia; Liver; Renin; Renin-Angiotensin System; Shock, Cardiogenic; Splanchnic Circulation; Swine; Sympathetic Nervous System; Vascular Resistance | 1986 |
[Problems in the treatment of cardiogenic shock].
Topics: Angiotensin II; Humans; Myocardial Infarction; Norepinephrine; Shock, Cardiogenic; Vasoconstrictor Agents | 1970 |
[Problem of cardiogenic shock therapy].
Topics: Adrenal Cortex Hormones; Analgesics; Angiotensin II; Anticoagulants; Assisted Circulation; Benperidol; Cardiac Glycosides; Dextrans; Fibrinolytic Agents; Humans; Hydrocortisone; Myocardial Infarction; Neuroleptanalgesia; Norepinephrine; Phenoxybenzamine; Shock, Cardiogenic | 1970 |
Acute circulatory failure secondary to myocardial infarction.
Topics: Angiotensin II; Blood Pressure; Carbon Dioxide; Central Venous Pressure; Ephedrine; Hemodynamics; Humans; Hydrogen-Ion Concentration; Infusions, Parenteral; Metaraminol; Methoxamine; Myocardial Infarction; Norepinephrine; Oxygen; Partial Pressure; Phenylephrine; Regional Blood Flow; Shock, Cardiogenic | 1971 |
Intraaortic balloon pumping for ventricular septal defect or mitral regurgitation complicating acute myocardial infarction.
Topics: Adult; Angiography; Angiotensin II; Assisted Circulation; Blood Pressure; Cardiac Catheterization; Cardiac Output; Coronary Angiography; Electrocardiography; Female; Heart Auscultation; Heart Rate; Heart Septum; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Myocardial Infarction; Oxygen; Papillary Muscles; Pulmonary Artery; Rupture; Shock, Cardiogenic | 1973 |
Pharmacology of pressor agents on the systemic circulation.
Topics: Action Potentials; Angiotensin II; Animals; Blood Circulation; Blood Pressure; Epinephrine; Humans; Isoproterenol; Mephentermine; Metaraminol; Methoxamine; Norepinephrine; Phenylephrine; Pituitary Hormones, Posterior; Receptors, Adrenergic; Shock; Shock, Cardiogenic; Shock, Hemorrhagic; Vasoconstrictor Agents | 1973 |
Evaluation of the pharmacologic basis for the therapy of circulatory shock.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Blood Vessels; Digitalis Glycosides; Dopamine; Epinephrine; Glucocorticoids; Heart; Humans; Mephentermine; Norepinephrine; Regional Blood Flow; Shock, Cardiogenic; Sympatholytics; Sympathomimetics; Vasoconstrictor Agents; Vasodilator Agents | 1970 |